Publication | Closed Access

Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity

Carbapenemase ActivityAntimicrobial Drug DiscoveryPhotodynamic Therapy InhibitHealth SciencesPhotochemistryAntibioticsMedicineAntimicrobial SusceptibilityAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundPharmacologyClinical MicrobiologyAntimicrobial ResistanceRelevant β-LactamasesDrug Resistance